Subsequent studies found that multiple memory-cell subsets targeting different SARS-CoV-2 proteins could be detected in the convalescent blood of COVID-19 patients and that the proportion of virus-specific CD8+ T cells in patients with mild disease was higher than that in severe individuals [55,56]. This evidence concerns the gene CD8A and COVID-19.